US Patent Issued to LOXO ONCOLOGY on Feb. 17 for "Dosing of a Bruton's tyrosine kinase inhibitor" (California, Colorado, Pennsylvania Inventors)

ALEXANDRIA, Va., Feb. 17 -- United States Patent no. 12,551,463, issued on Feb. 17, was assigned to LOXO ONCOLOGY INC. (Indianapolis).

"Dosing of a Bruton's tyrosine kinase inhibitor" was invented by Barbara Jean Brandhuber (Golden, Colo.), Nora Chien Yee Ku (Woodside, Calif.), Nisha Nanda (San Francisco), Steven August Smith (San Jose, Calif.) and Donald Tsai (Springfield, Pa.).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention provides a method of administering doses of the BTK inhibitor, (S)-5-amino-3-(4-((5-fluoro-2-methoxybenzamido)methyl)phenyl)-1-(1,1,1-trifluoropropane-2-yl)-1H-pyrazole-4-carboxamide or a pharmaceutically acceptable salt thereof for use in treating conditions such as...